Dapagliflozin-induced integrated improvements in left ventricular diastole, endothelial function, and arterial load: a randomized clinical trial.

Cardiovasc Diabetol · 2026 · PMC13141266 · PMID 41888924

Europe PMC DOI

hedged sentence

0.1840

closest p · 3.7× alpha

0.1840

boldest claim

The sentences

did not reach statistical significancep = 0.184not close (p > 0.1)

Exploratory intragroup analysis revealed a reduction in the E/e’ ratio within the dapagliflozin group but the difference did not reach statistical significance [from 8.059 (95% CI 7.326–8.792) to 7.691 (95% CI 6.960–8.422); p = 0.184].

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.